Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
about
Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoterCancer cell metabolism: implications for therapeutic targetsIncrease of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration scheduleTherapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancerInduction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis.Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7.Drugs targeting the mitochondrial pore act as cytotoxic and cytostatic agents in temozolomide-resistant glioma cells.c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findingsStimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.Anticancer effects of amooranin in human colon carcinoma cell line in vitro and in nude mice xenografts.Lonidamine causes inhibition of angiogenesis-related endothelial cell functions.Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity.Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity.bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells.
P2860
Q24307441-0BBD03E5-F93C-4B34-AB45-57745F707F04Q27013632-E60D72A2-DDD6-4F3E-9D11-2B1B13992073Q28371265-01A80DC5-63EF-4391-A2DE-6574DF4EA491Q28476850-B2C95071-DD10-483D-A168-9F2D6F9C4D15Q31137239-F5A70868-33E4-471A-9AEA-C77AD52F2E5DQ33179316-98E3638B-583A-4B0C-A5CD-BBD4224A1A62Q33406013-82F15D45-F1DB-47EF-83F5-F30EC6DC777AQ35842076-3313B6B4-2EEC-4A64-AD1E-923E3F2DF742Q36295058-C7987108-849B-44F1-9D5D-BF66AF834B26Q36623312-79E46DEC-7F69-4FA6-8A93-B3C82A5707FDQ37280649-5CFFBA36-53E9-4AA9-91D4-FF47C68167E4Q40246079-AA3E91C7-6FB2-4A52-8708-5422A738E16DQ40490910-451CD98D-4AC6-47D6-9B35-AC32E016E073Q40615175-2F3FA1A7-510A-48BD-A545-EAB18632DA58Q40775397-5D436C66-9E67-4900-8DEE-2A7D1AC6D5B9Q40949883-2699F141-8126-416B-B80F-A0D0A5960CF3
P2860
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
@en
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
@nl
type
label
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
@en
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
@nl
prefLabel
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
@en
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
@nl
P2093
P2860
P356
P1476
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene
@en
P2093
P2860
P304
P356
10.1172/JCI118900
P407
P577
1996-09-01T00:00:00Z